In vitro studies have highlighted the combined effect of BMP4 and SHH in supporting the survival of prostate cancer cells and promoting the differentiation of bone stromal cells, which may lead to the osteoblastic metastasis typical of prostate cancer [80]. Here, BMP4 is linked to prostate carcinoma.